Literature DB >> 19584199

Preeclampsia and soluble fms-like tyrosine kinase 1.

James M Roberts, Augustine Rajakumar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19584199      PMCID： PMC2708948          DOI： 10.1210/jc.2009-0945

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  20 in total

Review 1.  Decidual and vascular pathophysiology in pregnancy compromise.

Authors:  K A Starzyk; R Pijnenborg; C M Salafia
Journal:  Semin Reprod Endocrinol       Date:  1999

2.  Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

Authors:  Carmen Urbich; Alexandra Aicher; Christopher Heeschen; Elisabeth Dernbach; Wolf K Hofmann; Andreas M Zeiher; Stefanie Dimmeler
Journal:  J Mol Cell Cardiol       Date:  2005-09-29       Impact factor: 5.000

3.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

4.  VEGF links hippocampal activity with neurogenesis, learning and memory.

Authors:  Lei Cao; Xiangyang Jiao; David S Zuzga; Yuhong Liu; Dahna M Fong; Deborah Young; Matthew J During
Journal:  Nat Genet       Date:  2004-07-18       Impact factor: 38.330

5.  Post-transcriptional control of expression of sFlt-1, an endogenous inhibitor of vascular endothelial growth factor.

Authors:  William R Huckle; Rebecca I Roche
Journal:  J Cell Biochem       Date:  2004-09-01       Impact factor: 4.429

6.  Circulating angiogenic factors and the risk of preeclampsia.

Authors:  Richard J Levine; Sharon E Maynard; Cong Qian; Kee-Hak Lim; Lucinda J England; Kai F Yu; Enrique F Schisterman; Ravi Thadhani; Benjamin P Sachs; Franklin H Epstein; Baha M Sibai; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

7.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.

Authors:  N Ferrara; K Carver-Moore; H Chen; M Dowd; L Lu; K S O'Shea; L Powell-Braxton; K J Hillan; M W Moore
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

8.  A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia.

Authors:  Christie P Thomas; Janet I Andrews; Nandita S Raikwar; Elizabeth A Kelley; Florian Herse; Ralf Dechend; Thaddeus G Golos; Kang Z Liu
Journal:  J Clin Endocrinol Metab       Date:  2009-03-31       Impact factor: 5.958

9.  Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer.

Authors:  Fairooz Kabbinavar; Herbert I Hurwitz; Louis Fehrenbacher; Neal J Meropol; William F Novotny; Grazyna Lieberman; Susan Griffing; Emily Bergsland
Journal:  J Clin Oncol       Date:  2003-01-01       Impact factor: 44.544

10.  Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression.

Authors:  L Miquerol; B L Langille; A Nagy
Journal:  Development       Date:  2000-09       Impact factor: 6.868
View more
  19 in total

1.  Preeclampsia and retinopathy of prematurity in preterm births.

Authors:  Xiao Dan Yu; D Ware Branch; S Ananth Karumanchi; Jun Zhang
Journal:  Pediatrics       Date:  2012-06-04       Impact factor: 7.124

2.  Preeclampsia: animal models for a human cure.

Authors:  Mira Aubuchon; Laura C Schulz; Danny J Schust
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-13       Impact factor: 11.205

3.  New-onset maternal gestational hypertension and risk of retinopathy of prematurity.

Authors:  Mohamed A Zayed; Abhineet Uppal; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-12       Impact factor: 4.799

4.  Decreased circulating soluble Tie2 levels in preeclampsia may result from inhibition of vascular endothelial growth factor (VEGF) signaling.

Authors:  Joyce F Sung; Xiujun Fan; Sabita Dhal; Bonnie K Dwyer; Anahita Jafari; Yasser Y El-Sayed; Maurice L Druzin; Nihar R Nayak
Journal:  J Clin Endocrinol Metab       Date:  2011-04-27       Impact factor: 5.958

5.  Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications.

Authors:  Xiujun Fan; Anshita Rai; Neeraja Kambham; Joyce F Sung; Nirbhai Singh; Matthew Petitt; Sabita Dhal; Rani Agrawal; Richard E Sutton; Maurice L Druzin; Sanjiv S Gambhir; Balamurali K Ambati; James C Cross; Nihar R Nayak
Journal:  J Clin Invest       Date:  2014-10-20       Impact factor: 14.808

6.  Tumor Necrosis Factor-alpha Blockade Improves Uterine Artery Resistance, Maternal Blood Pressure, and Fetal Growth in Placental Ischemic Rats.

Authors:  Olivia K Travis; Geilda A Tardo; Chelsea Giachelli; Shani Siddiq; Henry T Nguyen; Madison T Crosby; Tyler Johnson; Andrea K Brown; Jan M Williams; Denise C Cornelius
Journal:  Pregnancy Hypertens       Date:  2021-05-14       Impact factor: 2.494

7.  Adoptive transfer of placental ischemia-stimulated natural killer cells causes a preeclampsia-like phenotype in pregnant rats.

Authors:  Olivia K Travis; Cedar Baik; Geilda A Tardo; Lorena Amaral; Carmilya Jackson; Mallory Greer; Chelsea Giachelli; Tarek Ibrahim; Owen T Herrock; Jan M Williams; Denise C Cornelius
Journal:  Am J Reprod Immunol       Date:  2020-12-27       Impact factor: 3.777

Review 8.  Potentially increasing rates of hypertension in women of childbearing age and during pregnancy--be prepared!

Authors:  J Moodley
Journal:  Cardiovasc J Afr       Date:  2011 Nov-Dec       Impact factor: 1.167

Review 9.  Association of maternal hypertensive disorders with retinopathy of prematurity: A systematic review and meta-analysis.

Authors:  TingTing Zhu; Li Zhang; FengYan Zhao; Yi Qu; Dezhi Mu
Journal:  PLoS One       Date:  2017-04-07       Impact factor: 3.240

10.  Soluble Fms-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in Preeclampsia.

Authors:  Lissette C Sánchez-Aranguren; Cindy T Espinosa-González; Laura M González-Ortiz; Sandra M Sanabria-Barrera; Carlos E Riaño-Medina; Andrés F Nuñez; Asif Ahmed; Jeannette Vasquez-Vivar; Marcos López
Journal:  Front Physiol       Date:  2018-03-06       Impact factor: 4.566
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.